contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


the-italian-sachet-market-is-starting-to-gain-momentum

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

iZafe Group is a Life Science company focused on the development and marketing of digital medical solutions for home medication management. The company offers, among other things, a medication robot, SaaS solutions and a connected dosing bag. The products aim to reduce the risk of medication errors. Customers include individuals, pharmaceutical companies and public and private healthcare providers globally. iZafe Group is headquartered in Stockholm.

Izafe Group

iZafe Group (publ.) hereby announces that the partner Remedio has sold its concept to 12 pharmacies which in a short time have 2,000 active customers who receive their medicines in sachets."...

<div class="mfn-preamble"><p><strong>iZafe Group (publ.) hereby announces that the partner Remedio has sold its concept to 12 pharmacies which in a short time have 2,000 active customers who receive their medicines in sachets.</strong></p></div><div class="mfn-body"><p>"Getting the medicine in sachets is completely new to the Italian market and our concept is based on local pharmacies purchasing a machine to enable their customers to have the medicine delivered in sachets. In a short time, we have now succeeded in installing machines for packing medicine into sachets in 12 pharmacies. These pharmacies have in turn gotten 2,000 of their customers to start getting their medicines delivered in sachets. Of these, about 95% are users in nursing homes. We currently have a rate of 2 new pharmacies a month installing a machine.<br>&nbsp;<br>We will now start actively selling Dosell to these customers, but we will also start tests to introduce corportare version of Dosell, as most of our customers patients are now in nursing homes." says Alessandro Iadecola, CEO Remedio S.R.L.<br>&nbsp;<br>&nbsp;<br>"Getting several pharmacies to start packaging the medicines in sachets is absolutely crucial for Dosell, which is based on loading the medicine robot with these sachets. It will be exciting to follow the development on the Italian market, where it is now finally starting to gain momentum. Extra happy that so many nursing homes are starting to show interest in getting the medicine in sachets, as there are 3,000 nursing homes with over 300,000 beds in Italy." says Anders Segerström, CEO of iZafe Group AB.</p></div><div class="mfn-footer mfn-contacts mfn-56636653838f"><p><strong class="mfn-heading-1">Contacts</strong></p><hr><p>Anders&nbsp;Segerström, Chief Executive Officer&nbsp;<br>E-mail: <a rel="nofollow noopener" href="mailto:anders.segerstrom@izafegroup.com">anders.segerstrom@izafegroup.com</a><br>Phone&nbsp;number: <a>+46 70-875 14 12</a><br><br>iZafe Group AB (publ.) <br>Södra Fiskartorpsvägen 20<br>114 33 Stockholm</p><p>E-mail:&nbsp;<a rel="nofollow noopener" href="mailto:ir@izafegroup.com">ir@izafegroup.com</a><br><a rel="nofollow noopener" href="http://www.izafe.se/investor-relations/">www.izafe.se/investor-relations/</a></p></div><div class="mfn-footer mfn-about mfn-2ae9e9120422"><p><strong class="mfn-heading-1">About Us</strong></p><hr><p>iZafe Group is a Swedish&nbsp;Life-Science company that develops and markets medical and digital security solutions to create safer drug handling at home. The&nbsp;company’s digital&nbsp;medication dispenser Dosell reduces the risk of incorrect medication, increases security for family and relatives and relieves public care&nbsp;personnel. The products form a holistic concept that facilitates patient medication and gives those who are treated at home better conditions for a happy and safe life.&nbsp;Customers today consist of public and private care providers in Sweden, the Nordic countries and globally. iZafe Group sells primarily through well-established partners who already have long and deep customer relationships with the priority customer groups. The head office is located in Stockholm.</p><p>The company is listed on the NASDAQ First North Premier Growth Market. FNCA Sweden AB is the company's Certified Adviser. Phone: +46 (0) 8 528 00 399. E-mail: <a rel="nofollow noopener" href="mailto:info@fnca.se">info@fnca.se</a>. Further information is available at <a rel="nofollow noopener" href="http://www.izafe.se/investor-relations/">www.izafe.se/investor-relations/</a>.</p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong></p><hr><p><a rel="nofollow noopener" href="https://storage.mfn.se/18f998d7-58fb-432d-85bf-def4fab8135b/the-italian-sachet-market-is-starting-to-gain-momentum.pdf" class="mfn-generated mfn-primary">The Italian sachet market is starting to gain momentum</a></p></div>